Related Experiment Video
Updated: Aug 6, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes
Pauline Macheboeuf1, Carlos Contreras-Martel, Viviana Job
1Institut de Biologie Structurale Jean-Pierre Ebel (CNRS/CEA/UJF), UMR 5075, Laboratoire des Protéines Membranaires, Grenoble, France.
Abstract:
Bacterial cell division and daughter cell formation are complex mechanisms whose details are orchestrated by at least a dozen different proteins. Penicillin-binding proteins (PBPs), membrane-associated macromolecules which play key roles in the cell wall synthesis process, have been exploited for over 70 years as the targets of the highly successful beta-lactam antibiotics. The increasing incidence of beta-lactam resistant microorganisms, coupled to progress made in genomics, genetics and immunofluorescence microscopy techniques, have encouraged the intensive study of PBPs from a variety of bacterial species. In addition, the recent publication of high-resolution structures of PBPs from pathogenic organisms have shed light on the complex intertwining of drug resistance and cell division processes. In this review, we discuss structural, functional and biological features of such enzymes which, albeit having initially been identified several decades ago, are now being aggressively pursued as highly attractive targets for the development of novel antibiotherapies.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Bacterial Cell Wall
Production of Antibiotics
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...

